CAS 114246-80-9
:(R)-Ranolazine
Description:
(R)-Ranolazine is a pharmaceutical compound primarily used in the treatment of chronic angina and certain types of heart conditions. It functions as an antianginal agent by inhibiting the late sodium current in cardiac myocytes, which helps to improve myocardial oxygen consumption and reduce ischemic episodes. The compound is characterized by its chiral nature, with the (R)-enantiomer being the therapeutically active form. Ranolazine is typically administered in oral form and is known for its relatively low side effect profile compared to other antianginal medications. Its chemical structure includes a piperazine ring and a carboxamide group, contributing to its pharmacological properties. Additionally, ranolazine has a moderate solubility in water and is metabolized primarily by the liver, involving cytochrome P450 enzymes. It is important to monitor potential drug interactions, particularly with other medications that affect hepatic metabolism. Overall, (R)-Ranolazine represents a significant advancement in the management of angina, offering an alternative mechanism of action compared to traditional therapies.
Formula:C24H33N3O4
Synonyms:- (R)-Ranolazine Q: What is the CAS Number of
- (R)-RanolazineQ: What is
- 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[(2R)-2-hydroxy-3-(2-methoxyphenoxy)propyl]-
- (R)-Ranolazine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
(R)-Ranolazine
CAS:<p>(R)-Ranolazine is a potent inhibitor of kinases that has shown promise as an anticancer agent. It has been found to be effective against a variety of tumor cells, including those derived from human urine and Chinese hamster ovaries. (R)-Ranolazine works by inhibiting the activity of protein kinase C, which plays a key role in cancer cell growth and proliferation. This drug has also been shown to induce apoptosis in cancer cells, leading to their death. In addition to its anticancer properties, (R)-Ranolazine has been found to inhibit elastase, an enzyme involved in the breakdown of proteins. This inhibition may have potential therapeutic applications for conditions such as chronic obstructive pulmonary disease (COPD) and other inflammatory diseases. Overall, (R)-Ranolazine is a promising analog with potential therapeutic applications for cancer and other diseases involving abnormal kinase activity or inflammation.</p>Formula:C24H33N3O4Purity:Min. 95%Molecular weight:427.5 g/mol
